ADAMTS12 and urinary bladder cancer: It has been reported that LINC01929, which is highly expressed in advanced bladder cancer, upregulates the expression level of ADAMTS12 through competitive adsorption of miR-6875-5p, and based on this molecular mechanism, overexpressed miR-6875-5p inhibits the progression of bladder cancer [41].